Cubist Systematic Strategies, LLC Innate Pharma Sa Transaction History
Cubist Systematic Strategies, LLC
- $14.3 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding IPHA
# of Institutions
9Shares Held
242KCall Options Held
0Put Options Held
0-
Optiver Holding B.V. Amsterdam, P787.4KShares$200,0360.0% of portfolio
-
Exchange Traded Concepts, LLC86.2KShares$197,4820.0% of portfolio
-
Morgan Stanley New York, NY43.5KShares$99,6690.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il23.5KShares$53,8760.0% of portfolio
-
Barclays PLC London, X0412Shares$9430.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $183M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...